Can we refine the selection for adjuvant treatment in stage II colon cancer?
HTML-код
- Опубликовано: 21 июл 2024
- Earn CME for related activities: www.naccme.com/oln
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Axel Grothey assesses whether selection can be refined for adjuvant treatment in stage II colon cancer.
© 2018 Imedex, LLC.
![Chk Chk Boom - Stray Kids ストレイキッズ 스트레이 키즈 [Music Bank] | KBS WORLD TV 240719](http://i.ytimg.com/vi/63QPwqCRGcw/mqdefault.jpg)
Does it mean that in stage 2, 3 Colon cancer ( intermediate risk) with R0 resection and no circulating tumor DNA should not receive adjuvant chemo. Does it also mean that circulating DNA is superior to other high risk loco-regional, molecular markers ?
hi.did you find a good answer for your questions?
@@madresefonoon Not yet, our oncology friends shall find one or the other reason to add chemo in the adjuvant setting more so since liquid biopsy is not widely available.
@@khaliddurrani6432is not parafine block of previous biopsy available?